Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib
Thomas Gaillard, Jeanne Piketty, Jean-Guillaume Féron, N. Girard, Léa Pauly, Élodie Gauroy, Lauren Darrigues, Beatriz Grandal, Jean‐Yves Pierga, Anne‐Sophie Hamy, Fabien Reyal, Enora Laas
Topics & Concepts
MedicineBreast cancerRetrospective cohort studyRandomized controlled trialSentinel lymph nodeMastectomyInternal medicineAxillary Lymph Node DissectionSurgeryOncologyCancerClinical trialObservational studyDissection (medical)Lymph nodeAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies